Fingerprint
Dive into the research topics of 'Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically